<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article" xml:lang="EN"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Mediators Inflamm</journal-id><journal-id journal-id-type="publisher-id">MI</journal-id><journal-title>Mediators of Inflammation</journal-title><issn pub-type="ppub">0962-9351</issn><issn pub-type="epub">1466-1861</issn><publisher><publisher-name>Hindawi Publishing Corporation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">19229345</article-id><article-id pub-id-type="pmc">2643053</article-id><article-id pub-id-type="doi">10.1155/2008/792428</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>Postulated Role of Vasoactive Neuropeptide-Related Immunopathology of the Blood Brain Barrier and Virchow-Robin Spaces in the Aetiology of Neurological-Related Conditions</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Staines</surname><given-names>D. R.</given-names></name><xref ref-type="aff" rid="I1"><sup>1, 2</sup></xref><xref ref-type="aff" rid="I2"/></contrib><contrib contrib-type="author"><name><surname>Brenu</surname><given-names>E. W.</given-names></name><xref ref-type="aff" rid="I2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Marshall-Gradisnik</surname><given-names>S.</given-names></name><xref ref-type="aff" rid="I2"><sup>2</sup></xref><xref ref-type="corresp" rid="cor1">*</xref></contrib></contrib-group><aff id="I1"><sup>1</sup>Gold Coast Population Health Unit, Queensland Health, Southport, Gold Coast, Queensland 4215, Australia</aff><aff id="I2"><sup>2</sup>Population Health and Neuroimmunology Unit, Faculty of Health Science and Medicine, Bond University, Robina, Queensland 4229, Australia</aff><author-notes><corresp id="cor1">*S. Marshall-Gradisnik: <email>smarshal@bond.edu.au</email></corresp><fn fn-type="other"><p>Recommended by Fulvio D'Acquisto</p></fn></author-notes><pub-date pub-type="ppub"><year>2008</year></pub-date><pub-date pub-type="epub"><day>16</day><month>2</month><year>2009</year></pub-date><volume>2008</volume><elocation-id>792428</elocation-id><history><date date-type="received"><day>17</day><month>7</month><year>2008</year></date><date date-type="accepted"><day>16</day><month>12</month><year>2008</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2008 D. R. Staines et al.</copyright-statement><copyright-year>2008</copyright-year><license license-type="open-access"><p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></license></permissions><abstract><p>Vasoactive neuropeptides (VNs) such as pituitary                   adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal peptide                   (VIP) have critical roles as neurotransmitters, vasodilators including perfusion                   and hypoxia regulators, as well as immune and nociception modulators.                   They have key roles in blood vessels in the central nervous system (CNS)                   including maintaining functional integrity of the blood brain barrier (BBB)                   and blood spinal barrier (BSB). VNs are potent activators of adenylate cyclase and thus                   also have a key role in cyclic AMP production affecting regulatory T cell and                   other immune functions. Virchow-Robin spaces (VRSs) are perivascular compartments                   surrounding small vessels within the CNS and contain VNs.                   Autoimmunity of VNs or VN receptors may affect BBB and VRS function and,                   therefore, may contribute to the aetiology of neurological-related conditions                   including multiple sclerosis, Parkinson's disease, and amyotrophic lateral sclerosis.                   VN autoimmunity will likely affect CNS and immunological homeostasis.                   Various pharmacological and immunological treatments including phosphodiesterase inhibitors                   and plasmapheresis may be indicated.</p></abstract></article-meta></front><body><sec sec-type="section" id="sec1"><title>1. INTRODUCTION</title><p>Vasoactive neuropeptides (VNs) (e.g., pituitary adenylatecyclase-activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP)) are widely distributed in the central nervoussystem (CNS) and peripheral nervous system (PNS) including autonomic nervoussystem (ANS) and peripheral tissues including heart, lung, pancreas, adrenal gland, gonads, and gastrointestinal tract as well as immune cells and lymphatic system [<xref ref-type="bibr" rid="B1">1</xref>].</p><p>VNs have critical roles and functions as neurotransmitters andneuroregulators, neurotrophic stimulators, hormonal regulators, vasodilators (includingperfusion and hypoxia regulators), as well as immune and nociceptionmodulators. They have key roles in blood vessel function in the CNS and contribute to high-level neurologicalfunctions including memory and learning [<xref ref-type="bibr" rid="B2">2</xref>]. They have a well-described neuroprotective role [<xref ref-type="bibr" rid="B3">3</xref>] and act asinflammatory mediators in microglial activation [<xref ref-type="bibr" rid="B4">4</xref>].</p><p>VNs exert potent effects in metabolism as they have a vital role incyclic adenosine monophosphate (cAMP) production and regulation throughadenylate cyclase (AC) activation. Immunological dysregulation of vitalbiochemical and/or epigenetic mechanisms affecting VNs resulting in down-regulationof cAMP are possible pathways by which disease entities become manifest. Theirrole along with other neurotrophic factors [<xref ref-type="bibr" rid="B5">5</xref>] in maintaining cAMP levels [<xref ref-type="bibr" rid="B6">6</xref>]may be of vital importance for the integrity of blood brain barrier (BBB) and bloodspinal barrier (BSB).</p><p>BBB and BSB havetraditionally been regarded as the main barriers between the brain and spinalcord parenchyma and the intravascular compartment and are, therefore, importantin keeping immune cells and macromolecules from interfering with brain andspinal neurological processes. However, disruption of BBB and BSB is well known in certain pathological statessuggesting that they function more as a &#x0201c;sieve&#x0201d; rather than an absolutebarrier.</p><p>Virchow-Robinspaces (VRSs) are compartments surrounding small vessels within the CNSwhich contain interstitial fluid and, while some functional contact withsubarachnoid spaces may occur for solute exchange, they may not contain CSF ascommonly thought [<xref ref-type="bibr" rid="B7">7</xref>]. VRSs have important connections with lymphaticdrainage of the head and neck [<xref ref-type="bibr" rid="B8">8</xref>], havingintricate pial relations and providing a surface foractivity of neuropeptides, hormones, and cytokines. Pial cells may have a role in protecting the brain from exogenouscatecholamines [<xref ref-type="bibr" rid="B9">9</xref>], and VRS may have a complex role in leukocyte recruitmentacross the BBB [<xref ref-type="bibr" rid="B10">10</xref>].</p><p>VNs are known to have neuroprotective effects through hypoxiaprotection on passage through the BBB [<xref ref-type="bibr" rid="B11">11</xref>] via a transport mechanism which enablesthe intact peptides to enter the parenchymal space of the brain [<xref ref-type="bibr" rid="B12">12</xref>]. Additionally, VNs have protective effects on neurons and glial cells [<xref ref-type="bibr" rid="B13">13</xref>]. VNs mayhave a significant role in blood BBB/BSB function and likely assist in immune regulation of VRS in the brain and spinalcord. The present paper asserts that in view of the many vital roles of VNs in CNS neuroregulatory and immunological functionincluding BBB function, autoimmunity to VNs or VN receptors will havesignificant effects on homeostasis resulting in disease states.</p></sec><sec sec-type="section" id="sec2"><title>2. VASOACTIVE NEUROPEPTIDES INIMMUNOLOGICAL CONTROL</title><p>VNs exert influence over inflammatory control mechanisms including influencingTh1 to Th2 shift, and the suppression of TNF alpha [<xref ref-type="bibr" rid="B14">14</xref>] has been established incAMP participation in vascular dysfunction involving endothelial cells [<xref ref-type="bibr" rid="B15">15</xref>]. The VRS has been identified as a location for immunoreactive lymphocytes inpenetration of neuronal parenchyma [<xref ref-type="bibr" rid="B16">16</xref>]. Also, VIP has been identified in connection with neuronal function and VRS suggesting thatVIP may have a regulatory functionassociated with vasodilatation [<xref ref-type="bibr" rid="B17">17</xref>]. We assert that important immunoregulationoccurs in VRS and that this may involve VN regulation. Many regulatoryfunctions are dependent on IL-10 and IL-4, these may be compromised in VNfailure. Moreover, leakiness in BBB and BSB functions may encourage development or relapses in neurological conditions,such as multiple sclerosis (MS) [<xref ref-type="bibr" rid="B18">18</xref>].</p><p>Regulatory T cells (Tregs) function to control autoreactive T cellsin the periphery [<xref ref-type="bibr" rid="B19">19</xref>]. Moreover, Treg function is substantially influenced byVNs [<xref ref-type="bibr" rid="B20">20</xref>] and may also have influence over Th17 direction [<xref ref-type="bibr" rid="B21">21</xref>]. Loss of Tregfunction in VRS will, therefore, have significant implications for inflammatorycontrol. Moreover, Th17 development occurs under IL-6 and TGF beta influence [<xref ref-type="bibr" rid="B22">22</xref>],and this may be a key switching point from a protective Treg to an autoimmuneTh17 phenotype. Certainly, Th1 and Th17 ratios are important in brain and spinalinflammation regulation [<xref ref-type="bibr" rid="B23">23</xref>].</p><p>Interestingly, a number of seemingly unrelated disorders may beimplicated in this postulated pathology. For example, Crohn's disease (CD) and MSare inflammatory disorders with known Th1-directed cytokines and loss of Foxp3Treg function [<xref ref-type="bibr" rid="B24">24</xref>, <xref ref-type="bibr" rid="B25">25</xref>].</p><p>As VRS have important roles in controlling macrophage and perivascularinfiltrates in MS [<xref ref-type="bibr" rid="B26">26</xref>], their immunological function in relation to VNs becomesof considerable interest. Complement-fixing myelinolytic antigens have beenidentified in the VRS in early MS [<xref ref-type="bibr" rid="B27">27</xref>], indicating the possible involvement ofVRS in immune activity.</p></sec><sec sec-type="section" id="sec3"><title>3. POSTULATED VASOACTIVE NEUROPEPTIDEAUTOIMMUNITY AND THE BLOOD BRAIN BARRIER</title><p>VN autoimmunity has been postulated as a contributing cause for somefatigue-related conditions [<xref ref-type="bibr" rid="B28">28</xref>]. Thepresent paper explores the possible role VN immune dysregulation may have onVRS function and CNS activity asthis anatomical pathway may have a significant bearing on disease aetiology.</p><p>Because VNs are widely distributed in the CNS,neurovascular, and immune systems, they exert extraordinary influence onneurological, vascular, and immunological functions. Significantly, VNs exertmostly anti-inflammatory activities and loss of their function, for example,through autoimmune compromise, could become manifest as unmodulated activationof immune responses. Autoimmunity directed at VN guanine protein-coupledreceptors (GPCRs) is currently unproven and loss-of-function autoimmunity toGPCRs generally is not widely documented. However, parallels exist with otherconditions such as Sjogren's syndrome which has T cell and/or B cell antibodytargeting of acetylcholine GPCRs [<xref ref-type="bibr" rid="B29">29</xref>]. The role of VNs in linking the innateand acquired immune systems [<xref ref-type="bibr" rid="B30">30</xref>] suggests that there would be significant effectson homeostasis if compromised.</p><p>Pain, fatigue, and dysregulation of nociception may be prominentfeatures in these syndromes as a result of VN compromise in the CNS. Pain and nociception are mediated throughspinal and cerebral pathways particularly via spinothalamic, spinoreticular,and spinomesencephalic structures. The periaqueductal grey (PAG) region surrounding the third ventricle andcerebral aqueduct is a key area for regulation of noxious stimuli. This areahas high-density VN presence and may be a prominent target for VN autoimmunecompromise. Similarly, VRS have a critical role in maintaining the interstitialfluid immunological milieu and may be a vulnerable area for VN compromise.</p><p>It is likely that BBB, BSB, and VRS play an important role inimmunological maintenance and homeostasis within the CNS. Macrophages in VRS express MHC class II antigens and interact with lymphocytes from the blood in initiatingand promoting immune responses to foreign antigens in the brain. Immunologicalactivity within VRS may have a role in a number of neurological conditions. Moreover,sites deficient in BBB include the subarachnoid space and pial surface, and circumventricularorgans may be more prone to macromolecule penetration of CSF, and this may haveimplications regarding autoimmune dysfunction within the CNS [<xref ref-type="bibr" rid="B31">31</xref>]. Collectionsof macrophages may occur in VRS following trauma in a proinflammatory context  [<xref ref-type="bibr" rid="B32">32</xref>] and pathological dilatation of VRS mayoccur from a variety of causes including ischaemia [<xref ref-type="bibr" rid="B33">33</xref>].</p><p>VRS distribution in anatomically specific locations reflects thefunctional attributes of these locations. For example, VRS in the nucleustractus solitarius in the dorsal medulla oblongata suggests they may have arole in viscerosensory and autonomic functions [<xref ref-type="bibr" rid="B34">34</xref>]. Capillary diversity within the subfornical organ (SFO) and areapostrema (AP) may function as low-resistance pathways for the rapid dispersionof blood-borne hormones inside their organ boundaries and this may have a rolein the regulation of blood pressure and body fluids [<xref ref-type="bibr" rid="B35">35</xref>]. Hence, thesefunctions linked to VRS microanatomy may be particularly susceptible to VNcompromise.</p></sec><sec sec-type="section" id="sec4"><title>4. POSTULATED CEREBROVASCULAR ANDCNS EFFECTS OF VN FAILURE</title><p>Vascular compromise within the CNS possibly as a result of VN compromise may give rise to features consistent withcertain forms of dementia. Fronto-temporal dementia (FTD) is aneurodegenerative disease in which a vascular component is suggested andimmunoreactivity of Bax, a proapoptotic protein regulated in part by VNs inastrocytes, suggests a role for autoimmunity in the pathology of FTD [<xref ref-type="bibr" rid="B36">36</xref>]. Astrogliosis in FTD corresponds withSPECT hypoperfusion, suggesting that astrocyte disruption may be related to disturbancesof cerebral perfusion in FTD [<xref ref-type="bibr" rid="B37">37</xref>]. Cognitive dysfunction is associated withreduced cerebral blood flow in different types of dementia [<xref ref-type="bibr" rid="B38">38</xref>]. Moreover, VRSdilatation associated with microvessel abnormality may contribute to the diagnosisof vascular dementias [<xref ref-type="bibr" rid="B39">39</xref>]. Changesin social behaviour occur in cerebrovascular comprise and may result from anFTD-like syndrome [<xref ref-type="bibr" rid="B40">40</xref>]. Similarly, reduction in cortical blood flow has beenidentified in CFS patients [<xref ref-type="bibr" rid="B41">41</xref>, <xref ref-type="bibr" rid="B42">42</xref>];however, these findings were not replicated in a study of twins with CFS [<xref ref-type="bibr" rid="B43">43</xref>].</p><p>Astroglial water channel aquaporin (AQP4) is essential for themaintenance of blood-brain barrier integrity [<xref ref-type="bibr" rid="B44">44</xref>]. Antibodies to AQP4 have ahighly specific role in neuromyelitis optica (NMO) and characteristically bindto cerebral microvessels, pia mater, and VRSs [<xref ref-type="bibr" rid="B45">45</xref>]. Secretin is important forother aquaporin expression via vasopressin. Secretin receptor-null mice, forexample, have reduced renal expression of AQP2 and AQP4 [<xref ref-type="bibr" rid="B46">46</xref>]. Interestingly, VIP, which is related to secretin, also has arelationship with aquaporin distribution and function. An association with VRShas been identified supporting the view that cortical nerve cells release VIP in the perivascular space during periods ofactivity and thus contribute to local vasodilatation associated with neuronalfunction. There is an important relationship whereby ATP over expression has adown-regulatory impact on AQP4 expression [<xref ref-type="bibr" rid="B47">47</xref>]. Adenylate cyclase compromise could have an impact on ATP levels byfailure to convert to cAMP, arguably maintaining high levels of ATP withadverse consequences for AQP4 function. Thus, VN failure may present withdementia-like signs and symptoms.</p></sec><sec sec-type="section" id="sec5"><title>5. CONCLUSIONS</title><p>Neurological conditions often present with fatigue and othersymptoms including memory and concentration loss, emotional lability, andconfusion. Multisystem involvement including cerebrospinal effects of theseconditions may be explained in part through VN compromise. In particular, cerebrovascularand spinovascular compromise acting at the ultra-microscopic level involvingBBB and BSB may contribute to thesedisorders. Compromise of VN receptors critical to BBB and BSB functioning may have a role in these disordersand should be the subject of further research.</p><p>This paper asserts that CNS vascular compromise including immunological dysfunction of the VRS may belinked to postulated VN autoimmunity. Evidence for compromise of VN receptorsat different levels including VN receptor mRNA, protein transcription, cellularmigration and trafficking, cell membrane localisation, as well as possibleantibody or T cell targeting will be required to support this hypothesis.</p><p>There are significant treatment implications from this hypothesis. VNs,such as PACAP and VIP, exert potent effects in metabolism as they have a vitalrole in cAMP production and regulation through AC activation. Phosphodiesterase(PDE) enzymes metabolise cAMP as ameans of feedback regulation of cAMP levels. VN compromise will result inimpaired AC activation and hence impaired cAMP production. Thus,phosphodiesterase inhibitors (PDEIs), novel therapeutic substances used topromote cAMP levels, may have a role in treatment of VN autoimmune conditions.</p><p>Proof of this hypothesis will require demonstration of pathologicalantibodies or T cells specific to VN immunological pathology. Alternatively,antagonistic variants of VNs themselves may exist.</p></sec></body><back><ref-list><ref id="B1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vaudry</surname><given-names>D</given-names></name><name><surname>Gonzalez</surname><given-names>BJ</given-names></name><name><surname>Basille</surname><given-names>M</given-names></name><name><surname>Yon</surname><given-names>L</given-names></name><name><surname>Fournier</surname><given-names>A</given-names></name><name><surname>Vaudry</surname><given-names>H</given-names></name></person-group><article-title>Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions</article-title><source><italic>Pharmacological Reviews</italic></source><year>2000</year><volume>52</volume><issue>2</issue><fpage>269</fpage><lpage>324</lpage><pub-id pub-id-type="pmid">10835102</pub-id></citation></ref><ref id="B2"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>CJ</given-names></name><name><surname>Shioda</surname><given-names>S</given-names></name><name><surname>Yada</surname><given-names>T</given-names></name><name><surname>Inagaki</surname><given-names>N</given-names></name><name><surname>Pleasure</surname><given-names>SJ</given-names></name><name><surname>Kikuyama</surname><given-names>S</given-names></name></person-group><article-title>PACAP and its receptors exert pleiotropic effects in the nervous system by activating multiple signalling pathways</article-title><source><italic>Current Protein and Peptide Science</italic></source><year>2002</year><volume>3</volume><issue>4</issue><fpage>423</fpage><lpage>439</lpage><pub-id pub-id-type="pmid">12370005</pub-id></citation></ref><ref id="B3"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brenneman</surname><given-names>DE</given-names></name></person-group><article-title>Neuroprotection: a comparative view of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide</article-title><source><italic>Peptides</italic></source><year>2007</year><volume>28</volume><issue>9</issue><fpage>1720</fpage><lpage>1726</lpage><pub-id pub-id-type="pmid">17513014</pub-id></citation></ref><ref id="B4"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Delgado</surname><given-names>M</given-names></name><name><surname>Leceta</surname><given-names>J</given-names></name><name><surname>Ganea</surname><given-names>D</given-names></name></person-group><article-title>Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit the production of inflammatory mediators by activated microglia</article-title><source><italic>Journal of Leukocyte Biology</italic></source><year>2003</year><volume>73</volume><issue>1</issue><fpage>155</fpage><lpage>164</lpage><pub-id pub-id-type="pmid">12525573</pub-id></citation></ref><ref id="B5"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Igarashi</surname><given-names>Y</given-names></name><name><surname>Utsumi</surname><given-names>H</given-names></name><name><surname>Chiba</surname><given-names>H</given-names></name><etal/></person-group><article-title>Glial cell line-derived neurotrophic factor induces barrier function of endothelial cells forming the blood-brain barrier</article-title><source><italic>Biochemical and Biophysical Research Communications</italic></source><year>1999</year><volume>261</volume><issue>1</issue><fpage>108</fpage><lpage>112</lpage><pub-id pub-id-type="pmid">10405331</pub-id></citation></ref><ref id="B6"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baranczyk-Kuzma</surname><given-names>A</given-names></name><name><surname>Audus</surname><given-names>KL</given-names></name><name><surname>Guillot</surname><given-names>FL</given-names></name><name><surname>Borchardt</surname><given-names>RT</given-names></name></person-group><article-title>Effects of selected vasoactive substances on adenylate cyclase activity in brain, isolated brain microvessels and primary cultures of brain microvessel endothelial cells</article-title><source><italic>Neurochemical Research</italic></source><year>1992</year><volume>17</volume><issue>2</issue><fpage>209</fpage><lpage>214</lpage><pub-id pub-id-type="pmid">1311435</pub-id></citation></ref><ref id="B7"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>&#x000d6;zt&#x000fc;rk</surname><given-names>MH</given-names></name><name><surname>Ayding&#x000f6;z</surname><given-names>&#x000dc;</given-names></name></person-group><article-title>Comparison of MR signal intensities of cerebral perivascular (Virchow-Robin) and subarachnoid spaces</article-title><source><italic>Journal of Computer Assisted Tomography</italic></source><year>2002</year><volume>26</volume><issue>6</issue><fpage>902</fpage><lpage>904</lpage><pub-id pub-id-type="pmid">12488733</pub-id></citation></ref><ref id="B8"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Esiri</surname><given-names>MM</given-names></name><name><surname>Gay</surname><given-names>D</given-names></name></person-group><article-title>Immunological and neuropathological significance of the Virchow-Robin space</article-title><source><italic>Journal of the Neurological Sciences</italic></source><year>1990</year><volume>100</volume><issue>1-2</issue><fpage>3</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">2089138</pub-id></citation></ref><ref id="B9"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>ET</given-names></name><name><surname>Inman</surname><given-names>CBE</given-names></name><name><surname>Weller</surname><given-names>RO</given-names></name></person-group><article-title>Interrelationships of the pia mater and the perivascular (Virchow-Robin) spaces in the human cerebrum</article-title><source><italic>Journal of Anatomy</italic></source><year>1990</year><volume>170</volume><fpage>111</fpage><lpage>123</lpage><pub-id pub-id-type="pmid">2254158</pub-id></citation></ref><ref id="B10"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bechmann</surname><given-names>I</given-names></name><name><surname>Galea</surname><given-names>I</given-names></name><name><surname>Perry</surname><given-names>VH</given-names></name></person-group><article-title>What is the blood-brain barrier (not)?</article-title><source><italic>Trends in Immunology</italic></source><year>2007</year><volume>28</volume><issue>1</issue><fpage>5</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">17140851</pub-id></citation></ref><ref id="B11"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Takeda</surname><given-names>N</given-names></name><name><surname>Murozono</surname><given-names>M</given-names></name><name><surname>Watanabe</surname><given-names>S</given-names></name><name><surname>Isshiki</surname><given-names>A</given-names></name><name><surname>Watanabe</surname><given-names>Y</given-names></name></person-group><article-title>Neuroprotective effects of novel derivatives of vasoactive intestinal peptide and pituitary adenylate cyclase-activating peptide in two brain ischemic models on mice</article-title><source><italic>Japanese Journal of Anesthesiology</italic></source><year>2005</year><volume>54</volume><issue>3</issue><fpage>240</fpage><lpage>248</lpage><pub-id pub-id-type="pmid">15794099</pub-id></citation></ref><ref id="B12"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Banks</surname><given-names>WA</given-names></name><name><surname>Uchida</surname><given-names>D</given-names></name><name><surname>Arimura</surname><given-names>A</given-names></name><name><surname>Somogyv&#x000e1;ri-Vigh</surname><given-names>A</given-names></name><name><surname>Shioda</surname><given-names>S</given-names></name></person-group><article-title>Transport of pituitary adenylate cyclase-activating polypeptide across the blood-brain barrier and the prevention of ischemia-induced death of hippocampal neurons</article-title><source><italic>Annals of the New York Academy of Sciences</italic></source><year>1996</year><volume>805</volume><fpage>270</fpage><lpage>279</lpage><pub-id pub-id-type="pmid">8993409</pub-id></citation></ref><ref id="B13"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Masmoudi-Kouki</surname><given-names>O</given-names></name><name><surname>Gandolfo</surname><given-names>P</given-names></name><name><surname>Castel</surname><given-names>H</given-names></name><etal/></person-group><article-title>Role of PACAP and VIP in astroglial functions</article-title><source><italic>Peptides</italic></source><year>2007</year><volume>28</volume><issue>9</issue><fpage>1753</fpage><lpage>1760</lpage><pub-id pub-id-type="pmid">17655978</pub-id></citation></ref><ref id="B14"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Delgado</surname><given-names>M</given-names></name><name><surname>Abad</surname><given-names>C</given-names></name><name><surname>Martinez</surname><given-names>C</given-names></name><etal/></person-group><article-title>PACAP in immunity and inflammation</article-title><source><italic>Annals of the New York Academy of Sciences</italic></source><year>2003</year><volume>992</volume><fpage>141</fpage><lpage>157</lpage><pub-id pub-id-type="pmid">12794054</pub-id></citation></ref><ref id="B15"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Koga</surname><given-names>S</given-names></name><name><surname>Morris</surname><given-names>S</given-names></name><name><surname>Ogawa</surname><given-names>S</given-names></name><etal/></person-group><article-title>TNF modulates endothelial properties by decreasing cAMP</article-title><source><italic>American Journal of Physiology</italic></source><year>1995</year><volume>268</volume><issue>5</issue><fpage>C1104</fpage><lpage>C1113</lpage><pub-id pub-id-type="pmid">7762602</pub-id></citation></ref><ref id="B16"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tomimoto</surname><given-names>H</given-names></name><name><surname>Akiguchi</surname><given-names>I</given-names></name><name><surname>Akiyama</surname><given-names>H</given-names></name><name><surname>Kimura</surname><given-names>J</given-names></name><name><surname>Yanagihara</surname><given-names>T</given-names></name></person-group><article-title>T-cell infiltration and expression of MHC class II antigen by macrophages and microglia in a heterogeneous group in leukoencephalopathy</article-title><source><italic>American Journal of Pathology</italic></source><year>1993</year><volume>143</volume><issue>2</issue><fpage>579</fpage><lpage>586</lpage><pub-id pub-id-type="pmid">8102032</pub-id></citation></ref><ref id="B17"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>E-T</given-names></name><name><surname>Mikkelsen</surname><given-names>JD</given-names></name><name><surname>Fahrenkrug</surname><given-names>J</given-names></name><name><surname>M&#x000f8;ller</surname><given-names>M</given-names></name><name><surname>Kronborg</surname><given-names>D</given-names></name><name><surname>Lauritzen</surname><given-names>M</given-names></name></person-group><article-title>Prepro-vasoactive intestinal polypeptide-derived peptide sequences in cerebral blood vessels of rats: on the functional anatomy of metabolic autoregulation</article-title><source><italic>Journal of Cerebral Blood Flow &#x00026; Metabolism</italic></source><year>1991</year><volume>11</volume><issue>6</issue><fpage>932</fpage><lpage>938</lpage><pub-id pub-id-type="pmid">1939387</pub-id></citation></ref><ref id="B18"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Odoardi</surname><given-names>F</given-names></name><name><surname>Kawakami</surname><given-names>N</given-names></name><name><surname>Klinkert</surname><given-names>WEF</given-names></name><name><surname>Wekerle</surname><given-names>H</given-names></name><name><surname>Fl&#x000fc;gel</surname><given-names>A</given-names></name></person-group><article-title>Blood-borne soluble protein antigen intensifies T cell activation in autoimmune CNS lesions and exacerbates clinical disease</article-title><source><italic>Proceedings of the National Academy of Sciences of the United States of America</italic></source><year>2007</year><volume>104</volume><issue>47</issue><fpage>18625</fpage><lpage>18630</lpage><pub-id pub-id-type="pmid">18000062</pub-id></citation></ref><ref id="B19"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Romagnani</surname><given-names>S</given-names></name></person-group><article-title>Regulation of the T cell response</article-title><source><italic>Clinical &#x00026; Experimental Allergy</italic></source><year>2006</year><volume>36</volume><issue>11</issue><fpage>1357</fpage><lpage>1366</lpage><pub-id pub-id-type="pmid">17083345</pub-id></citation></ref><ref id="B20"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Delgado</surname><given-names>M</given-names></name><name><surname>Chorny</surname><given-names>A</given-names></name><name><surname>Gonzalez-Rey</surname><given-names>E</given-names></name><name><surname>Ganea</surname><given-names>D</given-names></name></person-group><article-title>Vasoactive intestinal peptide generates CD4<sup>+</sup>CD25<sup>+</sup> regulatory T cells in vivo</article-title><source><italic>Journal of Leukocyte Biology</italic></source><year>2005</year><volume>78</volume><issue>6</issue><fpage>1327</fpage><lpage>1338</lpage><pub-id pub-id-type="pmid">16204628</pub-id></citation></ref><ref id="B21"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Leceta</surname><given-names>J</given-names></name><name><surname>Gomariz</surname><given-names>RP</given-names></name><name><surname>Martinez</surname><given-names>C</given-names></name><name><surname>Carri&#x000f3;n</surname><given-names>M</given-names></name><name><surname>Arranz</surname><given-names>A</given-names></name><name><surname>Juarranz</surname><given-names>Y</given-names></name></person-group><article-title>Vasoactive intestinal peptide regulates Th17 function in autoimmune inflammation</article-title><source><italic>NeuroImmunoModulation</italic></source><year>2007</year><volume>14</volume><issue>3-4</issue><fpage>134</fpage><lpage>138</lpage><pub-id pub-id-type="pmid">18073504</pub-id></citation></ref><ref id="B22"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Oukka</surname><given-names>M</given-names></name></person-group><article-title>Interplay between pathogenic Th17 and regulatory T cells</article-title><source><italic>Annals of the Rheumatic Diseases</italic></source><year>2007</year><volume>66</volume><issue>supplement 3</issue><fpage>iii87</fpage><lpage>iii90</lpage><pub-id pub-id-type="pmid">17934104</pub-id></citation></ref><ref id="B23"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stromnes</surname><given-names>IM</given-names></name><name><surname>Cerretti</surname><given-names>LM</given-names></name><name><surname>Liggitt</surname><given-names>D</given-names></name><name><surname>Harris</surname><given-names>RA</given-names></name><name><surname>Goverman</surname><given-names>JM</given-names></name></person-group><article-title>Differential regulation of central nervous system autoimmunity by T<sub>H</sub>1 and T<sub>H</sub>17 cells</article-title><source><italic>Nature Medicine</italic></source><year>2008</year><volume>14</volume><issue>3</issue><fpage>337</fpage><lpage>342</lpage><pub-id pub-id-type="pmid">18278054</pub-id></citation></ref><ref id="B24"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ricciardelli</surname><given-names>I</given-names></name><name><surname>Lindley</surname><given-names>KJ</given-names></name><name><surname>Londei</surname><given-names>M</given-names></name><name><surname>Quaratino</surname><given-names>S</given-names></name></person-group><article-title>Anti tumour necrosis-<italic>&#x003b1;</italic> therapy increases the number of FOXP3<sup>+</sup> regulatory T cells in children affected by Crohn's disease</article-title><source><italic>Immunology</italic></source><year>2008</year><volume>125</volume><issue>2</issue><fpage>178</fpage><lpage>183</lpage><pub-id pub-id-type="pmid">18422560</pub-id></citation></ref><ref id="B25"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vandenbark</surname><given-names>AA</given-names></name><name><surname>Culbertson</surname><given-names>NE</given-names></name><name><surname>Bartholomew</surname><given-names>RM</given-names></name><etal/></person-group><article-title>Therapeutic vaccination with a trivalent T-cell receptor (TCR) peptide vaccine restores deficient <italic>FoxP3</italic> expression and TCR recognition in subjects with multiple sclerosis</article-title><source><italic>Immunology</italic></source><year>2008</year><volume>123</volume><issue>1</issue><fpage>66</fpage><lpage>78</lpage><pub-id pub-id-type="pmid">17944900</pub-id></citation></ref><ref id="B26"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>van Horssen</surname><given-names>J</given-names></name><name><surname>B&#x000f6;</surname><given-names>L</given-names></name><name><surname>Vos</surname><given-names>CMP</given-names></name><name><surname>Virtanen</surname><given-names>I</given-names></name><name><surname>de Vries</surname><given-names>HE</given-names></name></person-group><article-title>Basement membrane proteins in multiple sclerosis-associated inflammatory cuffs: potential role in influx and transport of leukocytes</article-title><source><italic>Journal of Neuropathology and Experimental Neurology</italic></source><year>2005</year><volume>64</volume><issue>8</issue><fpage>722</fpage><lpage>729</lpage><pub-id pub-id-type="pmid">16106221</pub-id></citation></ref><ref id="B27"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gay</surname><given-names>FW</given-names></name></person-group><article-title>Early cellular events in multiple sclerosis: intimations of an extrinsic myelinolytic antigen</article-title><source><italic>Clinical Neurology and Neurosurgery</italic></source><year>2006</year><volume>108</volume><issue>3</issue><fpage>234</fpage><lpage>240</lpage><pub-id pub-id-type="pmid">16364541</pub-id></citation></ref><ref id="B28"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Staines</surname><given-names>DR</given-names></name></person-group><article-title>Postulated vasoactive neuropeptide autoimmunity in fatigue-related conditions: a brief review and hypothesis</article-title><source><italic>Clinical and Developmental Immunology</italic></source><year>2006</year><volume>13</volume><issue>1</issue><fpage>25</fpage><lpage>39</lpage><pub-id pub-id-type="pmid">16603442</pub-id></citation></ref><ref id="B29"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gordon</surname><given-names>TP</given-names></name><name><surname>Bolstad</surname><given-names>AI</given-names></name><name><surname>Rischmueller</surname><given-names>M</given-names></name><name><surname>Jonsson</surname><given-names>R</given-names></name><name><surname>Waterman</surname><given-names>SA</given-names></name></person-group><article-title>Autoantibodies in primary Sj&#x000f6;gren's syndrome: new insights into mechanisms of autoantibody diversification and disease pathogenesis</article-title><source><italic>Autoimmunity</italic></source><year>2001</year><volume>34</volume><issue>2</issue><fpage>123</fpage><lpage>132</lpage><pub-id pub-id-type="pmid">11905842</pub-id></citation></ref><ref id="B30"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Delgado</surname><given-names>M</given-names></name><name><surname>Ganea</surname><given-names>D</given-names></name></person-group><article-title>Inhibition of IFN-<italic>&#x003b3;</italic>-induced Janus kinase-1-STAT1 activation in macrophages by vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide</article-title><source><italic>The Journal of Immunology</italic></source><year>2000</year><volume>165</volume><issue>6</issue><fpage>3051</fpage><lpage>3057</lpage><pub-id pub-id-type="pmid">10975815</pub-id></citation></ref><ref id="B31"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Broadwell</surname><given-names>RD</given-names></name><name><surname>Sofroniew</surname><given-names>MV</given-names></name></person-group><article-title>Serum proteins bypass the blood-brain fluid barriers for extracellular entry to the central nervous system</article-title><source><italic>Experimental Neurology</italic></source><year>1993</year><volume>120</volume><issue>2</issue><fpage>245</fpage><lpage>263</lpage><pub-id pub-id-type="pmid">8491281</pub-id></citation></ref><ref id="B32"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mueller</surname><given-names>C-A</given-names></name><name><surname>Schluesener</surname><given-names>HJ</given-names></name><name><surname>Conrad</surname><given-names>S</given-names></name><name><surname>Meyermann</surname><given-names>R</given-names></name><name><surname>Schwab</surname><given-names>JM</given-names></name></person-group><article-title>Spinal cord injury induces lesional expression of the proinflammatory and antiangiogenic cytokine EMAP II</article-title><source><italic>Journal of Neurotrauma</italic></source><year>2003</year><volume>20</volume><issue>10</issue><fpage>1007</fpage><lpage>1015</lpage><pub-id pub-id-type="pmid">14588117</pub-id></citation></ref><ref id="B33"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shiratori</surname><given-names>K</given-names></name><name><surname>Mrowka</surname><given-names>M</given-names></name><name><surname>Toussaint</surname><given-names>A</given-names></name><name><surname>Spalke</surname><given-names>G</given-names></name><name><surname>Bien</surname><given-names>S</given-names></name></person-group><article-title>Extreme, unilateral widening of Virchow-Robin spaces: case report</article-title><source><italic>Neuroradiology</italic></source><year>2002</year><volume>44</volume><issue>12</issue><fpage>990</fpage><lpage>992</lpage><pub-id pub-id-type="pmid">12483444</pub-id></citation></ref><ref id="B34"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gross</surname><given-names>PM</given-names></name><name><surname>Wall</surname><given-names>KM</given-names></name><name><surname>Pang</surname><given-names>JJ</given-names></name><name><surname>Shaver</surname><given-names>SW</given-names></name><name><surname>Wainman</surname><given-names>DS</given-names></name></person-group><article-title>Microvascular specializations promoting rapid interstitial solute dispersion in nucleus tractus solitarius</article-title><source><italic>American Journal of Physiology</italic></source><year>1990</year><volume>259</volume><issue>6</issue><fpage>R1131</fpage><lpage>R1138</lpage><pub-id pub-id-type="pmid">2260724</pub-id></citation></ref><ref id="B35"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gross</surname><given-names>PM</given-names></name></person-group><article-title>Morphology and physiology of capillary systems in subregions of the subfornical organ and area postrema</article-title><source><italic>Canadian Journal of Physiology and Pharmacology</italic></source><year>1991</year><volume>69</volume><issue>7</issue><fpage>1010</fpage><lpage>1025</lpage><pub-id pub-id-type="pmid">1954559</pub-id></citation></ref><ref id="B36"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nichol</surname><given-names>KE</given-names></name><name><surname>Kim</surname><given-names>R</given-names></name><name><surname>Cotman</surname><given-names>CW</given-names></name></person-group><article-title>Bcl-2 family protein behavior in frontotemporal dementia implies vascular involvement</article-title><source><italic>Neurology</italic></source><year>2001</year><volume>56</volume><issue>11</issue><supplement>supplement 4</supplement><fpage>S35</fpage><lpage>S40</lpage><pub-id pub-id-type="pmid">11402149</pub-id></citation></ref><ref id="B37"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Martinac</surname><given-names>JA</given-names></name><name><surname>Craft</surname><given-names>DK</given-names></name><name><surname>Su</surname><given-names>JH</given-names></name><name><surname>Kim</surname><given-names>RC</given-names></name><name><surname>Cotman</surname><given-names>CW</given-names></name></person-group><article-title>Astrocytes degenerate in frontotemporal dementia: possible relation to hypoperfusion</article-title><source><italic>Neurobiology of Aging</italic></source><year>2001</year><volume>22</volume><issue>2</issue><fpage>195</fpage><lpage>207</lpage><pub-id pub-id-type="pmid">11182469</pub-id></citation></ref><ref id="B38"><label>38</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Osawa</surname><given-names>A</given-names></name><name><surname>Maeshima</surname><given-names>S</given-names></name><name><surname>Shimamoto</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Relationship between cognitive function and regional cerebral blood flow in different types of dementia</article-title><source><italic>Disability and Rehabilitation</italic></source><year>2004</year><volume>26</volume><issue>12</issue><fpage>739</fpage><lpage>745</lpage><pub-id pub-id-type="pmid">15204497</pub-id></citation></ref><ref id="B39"><label>39</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Patankar</surname><given-names>TF</given-names></name><name><surname>Mitra</surname><given-names>D</given-names></name><name><surname>Varma</surname><given-names>A</given-names></name><name><surname>Snowden</surname><given-names>J</given-names></name><name><surname>Neary</surname><given-names>D</given-names></name><name><surname>Jackson</surname><given-names>A</given-names></name></person-group><article-title>Dilatation of the Virchow-Robin space is a sensitive indicator of cerebral microvascular disease: study in elderly patients with dementia</article-title><source><italic>American Journal of Neuroradiology</italic></source><year>2005</year><volume>26</volume><issue>6</issue><fpage>1512</fpage><lpage>1520</lpage><pub-id pub-id-type="pmid">15956523</pub-id></citation></ref><ref id="B40"><label>40</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nakano</surname><given-names>S</given-names></name><name><surname>Asada</surname><given-names>T</given-names></name><name><surname>Yamashita</surname><given-names>F</given-names></name><etal/></person-group><article-title>Relationship between antisocial behavior and regional cerebral blood flow in frontotemporal dementia</article-title><source><italic>NeuroImage</italic></source><year>2006</year><volume>32</volume><issue>1</issue><fpage>301</fpage><lpage>306</lpage><pub-id pub-id-type="pmid">16624585</pub-id></citation></ref><ref id="B41"><label>41</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ichise</surname><given-names>M</given-names></name><name><surname>Salit</surname><given-names>IE</given-names></name><name><surname>Abbey</surname><given-names>SE</given-names></name><etal/></person-group><article-title>Assessment of regional cerebral perfusion by 99Tcm-HMPAO SPECT in chronic fatigue syndrome</article-title><source><italic>Nuclear Medicine Communications</italic></source><year>1992</year><volume>13</volume><issue>10</issue><fpage>767</fpage><lpage>772</lpage><pub-id pub-id-type="pmid">1491843</pub-id></citation></ref><ref id="B42"><label>42</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yoshiuchi</surname><given-names>K</given-names></name><name><surname>Farkas</surname><given-names>J</given-names></name><name><surname>Natelson</surname><given-names>BH</given-names></name></person-group><article-title>Patients with chronic fatigue syndrome have reduced absolute cortical blood flow</article-title><source><italic>Clinical Physiology and Functional Imaging</italic></source><year>2006</year><volume>26</volume><issue>2</issue><fpage>83</fpage><lpage>86</lpage><pub-id pub-id-type="pmid">16494597</pub-id></citation></ref><ref id="B43"><label>43</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>DH</given-names></name><name><surname>Mayberg</surname><given-names>HS</given-names></name><name><surname>Fischer</surname><given-names>ME</given-names></name><etal/></person-group><article-title>Monozygotic twins discordant for chronic fatigue syndrome: regional cerebral blood flow SPECT</article-title><source><italic>Radiology</italic></source><year>2001</year><volume>219</volume><issue>3</issue><fpage>766</fpage><lpage>773</lpage><pub-id pub-id-type="pmid">11376266</pub-id></citation></ref><ref id="B44"><label>44</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Kong</surname><given-names>H</given-names></name><name><surname>Hua</surname><given-names>X</given-names></name><name><surname>Xiao</surname><given-names>M</given-names></name><name><surname>Ding</surname><given-names>J</given-names></name><name><surname>Hu</surname><given-names>G</given-names></name></person-group><article-title>Altered blood-brain barrier integrity in adult aquaporin-4 knockout mice</article-title><source><italic>NeuroReport</italic></source><year>2008</year><volume>19</volume><issue>1</issue><fpage>1</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">18281883</pub-id></citation></ref><ref id="B45"><label>45</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jarius</surname><given-names>S</given-names></name><name><surname>Paul</surname><given-names>F</given-names></name><name><surname>Franciotta</surname><given-names>D</given-names></name><etal/></person-group><article-title>Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica</article-title><source><italic>Nature Clinical Practice Neurology</italic></source><year>2008</year><volume>4</volume><issue>4</issue><fpage>202</fpage><lpage>214</lpage><pub-id pub-id-type="pmid">18334978</pub-id></citation></ref><ref id="B46"><label>46</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chu</surname><given-names>JYS</given-names></name><name><surname>Chung</surname><given-names>SCK</given-names></name><name><surname>Lam</surname><given-names>AKM</given-names></name><name><surname>Tam</surname><given-names>S</given-names></name><name><surname>Chung</surname><given-names>SK</given-names></name><name><surname>Chow</surname><given-names>BKC</given-names></name></person-group><article-title>Phenotypes developed in secretin receptor-null mice indicated a role for secretin in regulating renal water reabsorption</article-title><source><italic>Molecular and Cellular Biology</italic></source><year>2007</year><volume>27</volume><issue>7</issue><fpage>2499</fpage><lpage>2511</lpage><pub-id pub-id-type="pmid">17283064</pub-id></citation></ref><ref id="B47"><label>47</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>M</given-names></name><name><surname>Lee</surname><given-names>S-J</given-names></name><name><surname>Choi</surname><given-names>H-J</given-names></name><etal/></person-group><article-title>Regulation of AQP4 protein expression in rat brain astrocytes: role of P2X7 receptor activation</article-title><source><italic>Brain Research</italic></source><year>2008</year><volume>1195</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">18206860</pub-id></citation></ref></ref-list></back></article>